You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (22)

Journals (0)

1-10 of 22 results for original infliximab

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: A case report of drug-induced liver injury due to the infliximab biosimilar CT-P13 on switching from original infliximab in a patient with Crohn’s disease

Open access

Case report

First published 2022

A case report of drug-induced liver injury due to the infliximab biosimilar CT-P13 on switching from original infliximab in a patient with Crohn’s disease

Shin Kashima, Koji Sawada, Kentaro Moriichi [...]

Therapeutic Advances in Drug Safety

Select article: Long-term follow up after switching from original infliximab to an infliximab biosimilar: real-world data

Open access

Research article

First published 2019

Long-term follow up after switching from original infliximab to an infliximab biosimilar: real-world data

María Fernanda Guerra Veloz, María Belvis Jiménez, Teresa Valdes Delgado [...]

Therapeutic Advances in Gastroenterology

Select article: Discontinuation of infliximab treatment in patients with inflammatory bowel disease who retransitioned to originator and those who remained on biosimilar

Open access

Research article

First published 2023

Discontinuation of infliximab treatment in patients with inflammatory bowel disease who retransitioned to originator and those who remained on biosimilar

Rosanne W. Meijboom, Helga Gardarsdottir, Matthijs L. Becker [...]

Therapeutic Advances in Gastroenterology

Select article: Long-term effectiveness,safety and immunogenicity of the biosimilar SB2 in inflammatory bowel disease patients after switching from originator infliximab

Open access

Research article

First published 2021

Long-term effectiveness,safety and immunogenicity of the biosimilar SB2 in inflammatory bowel disease patients after switching from originator infliximab

Sarah Fischer, Sarah Cohnen, Entcho Klenske [...]

Therapeutic Advances in Gastroenterology

Select article: Switching from Infliximab Originator to SB2 Biosimilar in Inflammatory Bowel Diseases: A Multicentric Prospective Real-Life Study

Open access

Research article

First published 2021

Switching from Infliximab Originator to SB2 Biosimilar in Inflammatory Bowel Diseases: A Multicentric Prospective Real-Life Study

Davide Massimi, Brigida Barberio, Lorenzo Bertani [...]

Therapeutic Advances in Gastroenterology

Select article: Reverse switching from the biosimilar SB2 to the originator infliximab in previously switched patients with inflammatory bowel diseases: results of a prospective long-term cohort study

Open access

Research article

First published 2024

Reverse switching from the biosimilar SB2 to the originator infliximab in previously switched patients with inflammatory bowel diseases: results of a prospective long-term cohort study

Sarah Fischer, Moritz Donhauser, Sarah Cohnen [...]

Therapeutic Advances in Gastroenterology

Select article: Switching from originator infliximab to the biosimilar CT-P13 in 313 patients with inflammatory bowel disease

Open access

Research article

First published 2018

Switching from originator infliximab to the biosimilar CT-P13 in 313 patients with inflammatory bowel disease

Viktoria Bergqvist, Mohammad Kadivar, Daniel Molin [...]

Therapeutic Advances in Gastroenterology

Select article: Safety of Rapid Infliximab Biosimilar Infusions in Patients With Inflammatory Bowel Disease

Retricted access

Research article

First published 2022-3

Safety of Rapid Infliximab Biosimilar Infusions in Patients With Inflammatory Bowel Disease

Ji Yoon Kim, Shubha Bhat

Annals of Pharmacotherapy

Select article: Infliximab in inflammatory bowel disease

Open access

Review article

First published 2019

Infliximab in inflammatory bowel disease

Konstantinos Papamichael, Steve Lin, Matthew Moore [...]

Sage Open Chronic Disease

Select article: Infliximab Pricing in International Economic Evaluations in Inflammatory Bowel Disease to Inform Biologic and Biosimilar Access Policies: A Systematic Review

Open access

Review article

First published 2023-1

Infliximab Pricing in International Economic Evaluations in Inflammatory Bowel Disease to Inform Biologic and Biosimilar Access Policies: A Systematic Review

Naazish S. Bashir, Avery Hughes, Wendy J. Ungar

MDM Policy & Practice

1
2
3
10 / page

Article type

Publication date

Subjects

Access